Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cho-Hung Chiang

Showing results (31-40 of 52) with videos related to

Pageof 6
Sort By:
Journal of the American Academy of Dermatology|March 1, 2025
Cytotoxic T-lymphocyte associated protein 4 inhibitors are associated with a higher risk of cardiovascular events than programmed cell death protein 1 inhibitors in patients with melanomaChing-Chung Chang, Shao-Wei Lo, Hua-Ching Chang, et al.
Journal of Thrombosis and Thrombolysis|April 26, 2024
Thromboprophylaxis for outpatients with COVID-19: a Systematic Review and Meta-analysisCho-Han Chiang, Omer Ahmed, Weitao Liu, et al.
Cancer Letters|September 27, 2024
The incidence and risk of cardiovascular events associated with pembrolizumab in patients with breast cancerCho-Han Chiang, Xiaocao Haze Xu, Junmin Song, et al.
Oncology|May 21, 2025
Statin and Immune-Related Cardiovascular Events in Lung Cancer Patients Receiving Immune Checkpoint InhibitorsJunmin Song, Kuan-Yu Chi, Hyein Jeon, et al.
Cancer Medicine|February 24, 2023
The impact of peroxisome proliferator-activated receptor-γ activating angiotensin receptor blocker on outcomes of patients receiving immunotherapyCho-Han Chiang, Yu-Cheng Chang, Shih-Syuan Wang, et al.
Critical Care (London, England)|August 29, 2023
Effects of corticosteroids on severe community-acquired pneumonia: a closer look at the evidenceCho-Han Chiang, Xin Ya See, Tsu Hsien Wang, et al.
Pancreas|January 6, 2023
The Efficacy of Liposomal Irinotecan Plus Fluorouracil/Leucovorin as First-Line Therapy in Patients With Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma: A Single-Center Real-World StudyCho-Han Chiang, Cho-Hung Chiang, Cho-Hsien Chiang, et al.
Cancer Letters|July 5, 2024
Periodontitis is an immune-related adverse event associated with immune checkpoint inhibitors: A multi-center cohort studyKevin Sheng-Kai Ma, Cho-Hung Chiang, Steven T Chen, et al.
Oncology|May 28, 2023
Efficacy of Lipophilic Statins on Outcomes of Patients Treated with Immune Checkpoint InhibitorsCho-Han Chiang, Yuan-Jen Chen, Xin Ya See, et al.
Urologic Oncology|August 21, 2024
Clinical performance of Bladder EpiCheck™ versus voided urine cytology for detecting recurrence of nonmuscle invasive bladder cancer: Systematic review and meta-analysisCho-Han Chiang, Yu-Cheng Chang, Chun-Yu Peng, et al.
Pageof 6

Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
Journal of the American Academy of Dermatology|March 1, 2025
Cytotoxic T-lymphocyte associated protein 4 inhibitors are associated with a higher risk of cardiovascular events than programmed cell death protein 1 inhibitors in patients with melanomaChing-Chung Chang, Shao-Wei Lo, Hua-Ching Chang, et al.
Journal of Thrombosis and Thrombolysis|April 26, 2024
Thromboprophylaxis for outpatients with COVID-19: a Systematic Review and Meta-analysisCho-Han Chiang, Omer Ahmed, Weitao Liu, et al.
Cancer Letters|September 27, 2024
The incidence and risk of cardiovascular events associated with pembrolizumab in patients with breast cancerCho-Han Chiang, Xiaocao Haze Xu, Junmin Song, et al.
Oncology|May 21, 2025
Statin and Immune-Related Cardiovascular Events in Lung Cancer Patients Receiving Immune Checkpoint InhibitorsJunmin Song, Kuan-Yu Chi, Hyein Jeon, et al.
Cancer Medicine|February 24, 2023
The impact of peroxisome proliferator-activated receptor-γ activating angiotensin receptor blocker on outcomes of patients receiving immunotherapyCho-Han Chiang, Yu-Cheng Chang, Shih-Syuan Wang, et al.
Critical Care (London, England)|August 29, 2023
Effects of corticosteroids on severe community-acquired pneumonia: a closer look at the evidenceCho-Han Chiang, Xin Ya See, Tsu Hsien Wang, et al.
Pancreas|January 6, 2023
The Efficacy of Liposomal Irinotecan Plus Fluorouracil/Leucovorin as First-Line Therapy in Patients With Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma: A Single-Center Real-World StudyCho-Han Chiang, Cho-Hung Chiang, Cho-Hsien Chiang, et al.
Cancer Letters|July 5, 2024
Periodontitis is an immune-related adverse event associated with immune checkpoint inhibitors: A multi-center cohort studyKevin Sheng-Kai Ma, Cho-Hung Chiang, Steven T Chen, et al.
Oncology|May 28, 2023
Efficacy of Lipophilic Statins on Outcomes of Patients Treated with Immune Checkpoint InhibitorsCho-Han Chiang, Yuan-Jen Chen, Xin Ya See, et al.
Urologic Oncology|August 21, 2024
Clinical performance of Bladder EpiCheck™ versus voided urine cytology for detecting recurrence of nonmuscle invasive bladder cancer: Systematic review and meta-analysisCho-Han Chiang, Yu-Cheng Chang, Chun-Yu Peng, et al.
Pageof 6